NEFOPAM PANPHARMA 30 mg, film-coated tablet 30 tablets, CIP 3400930252512
Active ingredients: (RS)-nefopam hydrochloride
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet30 tablets, CIP 3400930252512orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- NEFOPAM PANPHARMA 30 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) aluminium PVC polyéthylène PVDC de 30 comprimé(s)
- Marketing authorisation holder
- LABORATOIRE CEVIDRA
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 22 Apr 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60601468CIP73025251CIP133400930252512Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE NÉFOPAMcomprimé | 30 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.